Corrigendum: The use of progeroid DNA repair-deficient mice for assessing anti-aging compounds, illustrating the benefits of nicotinamide riboside.

Autor:	Birkisdóttir MB; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands., van Galen I; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands., Brandt RMC; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands., Barnhoorn S; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands., van Vliet N; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands., van Dijk C; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands.; Department of Hematology, Erasmus University Medical Center, Rotterdam, Netherlands., Nagarajah B; Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands., Imholz S; Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands., van Oostrom CT; Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands., Reiling E; Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands., Gyenis Á; Faculty of Medicine, CECAD, Institute for Genome Stability in Aging and Disease, University of Cologne, Cologne, Germany., Mastroberardino PG; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands.; IFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.; Department of Life, Health, and Environmental Sciences, University of L'Aquila, L'Aquila, Italy., Jaarsma D; Department of Neuroscience, Erasmus University Medical Center, Rotterdam, Netherlands., van Steeg H; Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands., Hoeijmakers JHJ; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands.; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands.; Faculty of Medicine, CECAD, Institute for Genome Stability in Aging and Disease, University of Cologne, Cologne, Germany., Dollé MET; Centre for Health Protection, National Institute for Public Health and the Environment, (RIVM), Bilthoven, Netherlands., Vermeij WP; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Oncode Institute, Utrecht, Netherlands.
Jazyk:	angličtina
Zdroj:	Frontiers in aging [Front Aging] 2022 Nov 23; Vol. 3, pp. 1086552. Date of Electronic Publication: 2022 Nov 23 (Print Publication: 2022).
DOI:	10.3389/fragi.2022.1086552
Abstrakt:	[This corrects the article DOI: 10.3389/fragi.2022.1005322.]. (Copyright © 2022 Birkisdóttir, van Galen, Brandt, Barnhoorn, van Vliet, van Dijk, Nagarajah, Imholz, van Oostrom, Reiling, Gyenis, Mastroberardino, Jaarsma, van Steeg, Hoeijmakers, Dollé and Vermeij.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu